Published in Arch Intern Med on July 27, 1998
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
A test of financial incentives to improve warfarin adherence. BMC Health Serv Res (2008) 2.23
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis. CMAJ (2007) 1.29
Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both? Arch Intern Med (1998) 1.09
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med (2000) 1.08
Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation. PLoS One (2012) 0.99
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J (2014) 0.92
Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis. Medicine (Baltimore) (2015) 0.90
Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovasc Dis (2009) 0.89
Prevention of cardioembolic stroke. Neurotherapeutics (2011) 0.85
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord (2003) 0.85
Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents. Europace (2012) 0.84
Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis. J Am Heart Assoc (2016) 0.83
Advancement in antithrombotics for stroke prevention in atrial fibrillation. J Interv Card Electrophysiol (2008) 0.83
Effectiveness and safety of warfarin and anti-platelet drugs for the primary prevention of stroke in patients with non-valvular atrial fibrillation: a meta-analysis. Int J Clin Exp Med (2015) 0.80
Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation. Cardiovasc Ultrasound (2012) 0.80
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation. Clin Pharmacol (2016) 0.80
Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum Beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact. CADTH Technol Overv (2013) 0.78
A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior. Behav Anal (2014) 0.77
Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis (2013) 0.77
The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Ther Clin Risk Manag (2007) 0.76
Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran. Curr Control Trials Cardiovasc Med (2004) 0.75
Stroke prevention: age alone does not rule out warfarin. J Fam Pract (2007) 0.75
Managing atrial fibrillation in elderly people. What should target international normalised ratio be? BMJ (1999) 0.75
Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circ Arrhythm Electrophysiol (2016) 0.75
Warfarin vs aspirin and AFASAK 2. Arch Intern Med (1999) 0.75
Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation. Postgrad Med J (2005) 0.75
Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect. PLoS One (2016) 0.75
Major determinants for the selecting antithrombotic therapies in patients with nonvalvular atrial fibrillation in Japan (JAPAF study). J Arrhythm (2016) 0.75
Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis. PLoS One (2015) 0.75
Selecting antithrombotic therapy for patients with atrial fibrillation. Cleve Clin J Med (2015) 0.75
[Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference]. Herzschrittmacherther Elektrophysiol (2007) 0.75
Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials? J Interv Card Electrophysiol (2004) 0.75
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet (1989) 10.18
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet (2001) 3.69
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol (2006) 2.42
[Thrombolytic therapy is efficient only within the first three hours after ischemic apoplexy]. Ugeskr Laeger (1999) 2.02
Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg Med Chem Lett (1999) 1.99
Prestroke physical activity is associated with severity and long-term outcome from first-ever stroke. Neurology (2008) 1.86
Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand (1971) 1.83
Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol (2001) 1.79
Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int (2006) 1.75
An approach to emergency department photography. Acad Emerg Med (1995) 1.66
Embolic complications in paroxysmal atrial fibrillation. Stroke (1986) 1.44
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology (1999) 1.43
A unified form for neurological scoring of hemispheric stroke with motor impairment. Stroke (1992) 1.39
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med (1999) 1.39
Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrinol Metab (1968) 1.37
Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet (1992) 1.35
Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke (1985) 1.34
Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study. Stroke (1994) 1.29
Prevalence of stroke in a district of Copenhagen the copenhagen city heart study. Acta Neurol Scand (1982) 1.26
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST). J Neurol Neurosurg Psychiatry (2005) 1.21
Atrial fibrillation: natural history, complications, and management. Annu Rev Med (1988) 1.19
The effects of PaCO2 on regional cerebral blood flow and internal carotid arterial pressure during carotid clamping. Anesthesiology (1971) 1.18
Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry (2005) 1.16
Relation between EEG, regional cerebral blood flow and internal carotid artery pressure during carotid endarterectomy. Electroencephalogr Clin Neurophysiol (1973) 1.13
Interpretation of the electrocardiogram in suspected myocardial infarction: a randomized controlled study of the effect of a training programme to reduce interobserver variation. J Intern Med (1992) 1.11
Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study. Stroke (1993) 1.11
Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry (1979) 1.10
Central haemodynamic changes after a meal. Br Heart J (1989) 1.08
[Apoplexy units--European experiments]. Ugeskr Laeger (1996) 1.08
Acute neurological stroke care in Europe: results of the European Stroke Care Inventory. Eur J Neurol (2000) 1.06
Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Arch Intern Med (1990) 1.04
Acute effects of alcohol on left ventricular function in healthy subjects at rest and during upright exercise. Am J Cardiol (1985) 1.04
Blood glucose increases early after stroke onset: a study on serial measurements of blood glucose in acute stroke. Eur J Neurol (2002) 1.02
Natural history of vascular ring with clinical manifestations. A follow-up study of eleven unoperated cases. Scand J Thorac Cardiovasc Surg (1977) 1.02
The course of blood pressure in acute stroke is related to the severity of the neurological deficits. Acta Neurol Scand (2002) 1.00
Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet (1988) 1.00
The effect of trimethoprim on serum creatinine. Br J Urol (1985) 0.99
Cost of stroke in Europe. Eur J Neurol (2005) 0.99
Areal density measurement is a convenient method for the determination of porcine islet equivalents without counting and sizing individual islets. Cell Transplant (2003) 0.99
Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol (1984) 0.98
Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet (2001) 0.98
A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab (1992) 0.98
Silent cerebral infarction in chronic atrial fibrillation. Stroke (1988) 0.97
Costs of health care and social services during the first year after ischemic stroke. Int J Technol Assess Health Care (1999) 0.96
Cerebral blood flow before and after cardioversion of atrial fibrillation. J Cereb Blood Flow Metab (1989) 0.96
Autonomic nervous control of postprandial hemodynamic changes at rest and upright exercise. J Appl Physiol (1985) (1987) 0.95
Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study. J Neurol Sci (1992) 0.94
Prevention of thromboembolic events in atrial fibrillation. Thromb Haemost (1997) 0.94
Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy? Pain (1987) 0.93
Intake of beer, wine, and spirits and risk of stroke : the copenhagen city heart study. Stroke (1998) 0.93
99mTc-d,l-HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab (1991) 0.93
[Specific and non-specific effects of beta-adreno-receptor blocking drugs in man (author's transl)]. Klin Wochenschr (1976) 0.92
Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol (1992) 0.92
Thrombolytic treatment for stroke in the Scandinavian countries. Acta Neurol Scand (2009) 0.92
Intellectual function in patients with transient ischaemic attacks (TIA) or minor stroke. Long-term improvement after carotid endarterectomy. Acta Neurol Scand (1982) 0.92
Relation between left atrial dimension and duration of atrial fibrillation. Am J Cardiol (1987) 0.92
[Investigation of patients with transient cerebral ischemia]. Ugeskr Laeger (2000) 0.91
Postoperative cerebrovascular accidents in general surgery. Acta Anaesthesiol Scand (1988) 0.91
Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol (2000) 0.91
Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke (1999) 0.90
Chronic supraventricular tachycardia in infancy and childhood. Acta Paediatr Scand (1975) 0.90
Haemodynamic response to exercise in patients with alcoholic liver cirrhosis. Clin Physiol (1987) 0.90
Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model. Stroke (1992) 0.90
Paroxysmal tachycardia in infancy and childhood. II. Paroxysmal ventricular tachycardia and fibrillation. Acta Paediatr Scand (1973) 0.90
Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease. Stroke (1984) 0.89
Carotid surgery, cognitive function, and cerebral blood flow in patients with transient ischemic attacks. Ann Neurol (1986) 0.89
Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model. Acta Neurol Scand (1994) 0.89
McGill Pain Questionnaire translated into Danish: experimental and clinical findings. Clin J Pain (1993) 0.89
Treatment of chronic painful diabetic neuropathy with intravenous lidocaine infusion. Br Med J (Clin Res Ed) (1986) 0.88
Clinical, biochemical, immunological, and morphological features at time of diagnosis. Scand J Gastroenterol (1974) 0.88
Middle cerebral artery blood velocity during exercise in patients with atrial fibrillation. Clin Physiol (1999) 0.88
Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest (1986) 0.87
The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model. Brain Res (1994) 0.87
Cerebral hemodynamics in carotid surgery. Acta Neurol Scand Suppl (1973) 0.87
Torture and its treatment. Am J Public Health (1987) 0.87
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev (1997) 0.87
Dercum's disease (adiposis dolorosa). Treatment of the severe pain with intravenous lidocaine. Pain (1987) 0.86
Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation. Thromb Haemost (1997) 0.86
Fc-mediated immune precipitation. IV. Antigen dependency and specificity. Immunology (1983) 0.86
The reliability of measuring left ventricular ejection fraction by radionuclide cardiography: evaluation by the method of variance components. Br Heart J (1988) 0.86
Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol (1991) 0.86
Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease. Eur J Clin Invest (1985) 0.85
Direct costs during the first year after intracerebral hemorrhage. Eur J Neurol (1999) 0.85
Glycerol for acute stroke. Cochrane Database Syst Rev (2004) 0.85
Pulmonary hypertension secondary to minor pulmonary embolism. Chest (1978) 0.85
D-amphetamine improves cognitive deficits and physical therapy promotes fine motor rehabilitation in a rat embolic stroke model. Acta Neurol Scand (2006) 0.85
Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab (1994) 0.85